Arteris Q2 revenue rises 46%, beats estimates on strong AI, data-center demand
AIP•Analyst coverage
The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 5 "strong buy" or "buy", 1 "hold" and no "sell" or "strong sell".
The average consensus recommendation for the software peer group is "buy".
Wall Street's median 12-month price target for Arteris Inc is $39.00, about 26.1% above its August 5 closing price of $30.93.
Key quarterly metrics
| Metric | Beat/Miss | Actual | Consensus Estimate |
|---|---|---|---|
| Q2 Revenue | Beat | $24.10 million | $23.48 million (6 analysts) |
| Q2 Adjusted Net Loss | Miss | $4.70 million | $1.93 million (5 analysts) |
| Q2 Net Loss | $14.10 million | ||
| Q2 Adjusted Operating Income | Miss | -$4.60 million | -$2.29 million (6 analysts) |
| Q2 Operating Income | -$13.90 million |
Quarterly results and guidance
US semiconductor IP provider Arteris said second-quarter revenue rose 46% year over year, beating analyst expectations. Adjusted net loss and adjusted operating income for the quarter both missed analyst estimates.
Arteris sees third-quarter revenue between $24.0 million and $25.0 million. The company expects fiscal 2026 revenue between and and projects fiscal 2026 non-GAAP operating loss of .
